title: Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma.
authors.forename: Ariela
authors.initials: A
authors.lastname: Noy
authors.forename: Jamie
authors.initials: J
authors.lastname: von Roenn
authors.forename: Alex
authors.initials: A
authors.lastname: Politsmakher
authors.forename: Steven
authors.initials: S
authors.lastname: Miles
authors.forename: Claus
authors.initials: C
authors.lastname: Bernd
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D017093:Liver Failure / Q000150:complications* / Q000821:virology; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000150:complications* / Q000821:virology; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000821:virology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000821:virology
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; C116890:Semaxinib